Decreased Growth Factor Expression through RNA Interference Inhibits Development of Mouse Preimplantation Embryos
Abstract:Mitogenic growth factors play an important role in cellular development and differentiation. The purpose of this study was to assess the extent to which epidermal growth factor (EGF) and transforming growth factor α (TGFα) and their cognate receptor (EGFR) are crucial for normal preimplantation embryo development. We used RNA interference to decrease expression of growth factors in preimplantation mouse embryos. We microinjected 1-cell mouse embryos individually with short interfering RNA (siRNA) specific to EGF, TGFα, and EGFR and then analyzed temporal and spatial gene expression patterns at different stages of development before implantation. Transfection with siRNA significantly reduced growth factor expression in 1-cell, 2-cell, morula, early-blastocyst, and late-blastocyst embryos to levels similar to those in untreated 'cloned' embryos derived through intracytoplasmic nuclear injection. In addition, siRNA effectively decreased expression of maternally inherited genes between 24 and 72 h after transfection, with recovery of gene expression during late-blastocyst stage at 96 h after transfection. Furthermore, siRNA significantly decreased blastocyst formation, increased the number of apoptotic cells, and reduced the total number of differentiated cells in blastocysts; these changes were greatest after decreasing EGFR and of both EGF and TGFα simultaneously. These results support our hypothesis that EGF and TGFα are crucial for embryo survival and development. Further, dysregulated expression of growth factors is associated with poor development of cloned mouse embryos.
Document Type: Research Article
Affiliations: 1: Mouse Biology Program, Center for Comparative Medicine, School of Veterinary Medicine, University of California, Davis, California 2: Mouse Biology Program, Center for Comparative Medicine, School of Veterinary Medicine, University of California, Davis, California. firstname.lastname@example.org
Publication date: August 1, 2009
Comparative Medicine (CM), an international journal of comparative and experimental medicine, is the leading English-language publication in the field and is ranked by the Science Citation Index in the upper third of all scientific journals. The mission of CM is to disseminate high-quality, peer-reviewed information that expands biomedical knowledge and promotes human and animal health through the study of laboratory animal disease, animal models of disease, and basic biologic mechanisms related to disease in people and animals.
Attention Members: To access the full text of the articles, be sure you are logged in to the AALAS website.
Attention: please note, due to a temporary technical problem, reference linking within the content is not available at this time
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- For issues prior to 1998
- Institutional Subscription Activation
- ingentaconnect is not responsible for the content or availability of external websites